Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11045 results:
Συντάκτης [ Τίτλος(Desc)] Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
Barthélémy, F., Navarro C., Fayek R., Da Silva N., Roll P., Sigaudy S., et al. (2015).  Truncated prelamin A expression in HGPS-like patients: a transcriptional study.. Eur J Hum Genet. 23(8), 1051-61.
Polyzos, S. A., & Kountouras J. (2012).  Trying to treat diabetes in Greek crisis.. Int J Clin Pract. 66(5), 515.
Eleftheriadis, T., Pissas G., Sounidaki M., Antoniadi G., Rountas C., Liakopoulos V., et al. (2017).  Tryptophan depletion under conditions that imitate insulin resistance enhances fatty acid oxidation and induces endothelial dysfunction through reactive oxygen species-dependent and independent pathways.. Mol Cell Biochem. 428(1-2), 41-56.
Mintziori, G., & Goulis D. G. (2014).  TSH threshold for all women undergoing controlled ovarian stimulation.. Endocr Pract. 20(4), 374.
Mouslech, Z., Somali M., Sakali A. Konstantin, Savopoulos C., Mastorakos G., & Hatzitolios A. I. (2016).  TSH-secreting pituitary adenomas treated by gamma knife radiosurgery: our case experience and a review of the literature.. Hormones (Athens). 15(1), 122-8.
Kuhajda, I., Zarogoulidis K., Kougioumtzi I., Huang H., Li Q., Dryllis G., et al. (2014).  Tube thoracostomy; chest tube implantation and follow up.. J Thorac Dis. 6(Suppl 4), S470-9.
Manika, A., Kotoulas S. C., Papadaki E., Kyreltsi P., Sionidou M., Kontakiotis T., et al. (2019).  Tuberculosis treatment outcome in Thessaloniki, Greece - a single center study.. Hippokratia. 23(4), 154-159.
Cholongitas, E., Nakouti T., & Akriviadis E. (2014).  Tuberculous peritonitis after treatment for chronic hepatitis C.. Ann Gastroenterol. 27(4), 435-436.
Christoforidou, A., Metallidis S., Kollaras P., Agathangelidis A., Nikolaidis P., Vital V., et al. (2012).  Tuberculous retropharyngeal abscess as a cause of oropharyngeal dysphagia.. Am J Otolaryngol. 33(2), 272-4.
Salemis, N. S., Gemenetzis G., Karagkiouzis G., Seretis C., Sapounas K., Tsantilas V., et al. (2012).  Tubular adenoma of the breast: a rare presentation and review of the literature.. J Clin Med Res. 4(1), 64-7.
Spyridakis, I., Lopresti D., Georga S., Kepertis C., Efstratiou I., & Arsos G. (2017).  Tubular Intestinal Duplication Harboring Gastric Ectopia Accurately Diagnosed by Tc-99m Pertechnetate Single-photon Emission Computed Tomography/Computed Tomography Meckel's Scan.. Indian J Nucl Med. 32(4), 361-362.
Hatzibougias, D. I., Fouzas I., Bobos M., Papanikolaou V., Daoudaki M., Kotoula V., et al. (2016).  Tubular Pyloric Gland Adenoma of the Left and Right Hepatic Ducts: Report of a Unique Case With Immunohistochemical and Molecular Studies.. Int J Surg Pathol. 24(4), 347-52.
Katopodi, T., Petanidis S., Anestakis D., Charalampidis C., Chatziprodromidou I., Floros G., et al. (2023).  Tumor cell metabolic reprogramming and hypoxic immunosuppression: driving carcinogenesis to metastatic colonization.. Front Immunol. 14, 1325360.
Zarogoulidis, P., Papadopoulos V., Maragouli E., Papatsibas G., Karapantzos I., Bai C., et al. (2018).  Tumor heterogenicity: multiple needle biopsies from different lesion sites-key to successful targeted therapy and immunotherapy.. Transl Lung Cancer Res. 7(Suppl 1), S46-S48.
Kotoula, V., Lakis S., Vlachos I. S., Giannoulatou E., Zagouri F., Alexopoulou Z., et al. (2016).  Tumor Infiltrating Lymphocytes Affect the Outcome of Patients with Operable Triple-Negative Breast Cancer in Combination with Mutated Amino Acid Classes.. PLoS One. 11(9), e0163138.
Chatzopoulos, K., Kotoula V., Manoussou K., Markou K., Vlachtsis K., Angouridakis N., et al. (2020).  Tumor Infiltrating Lymphocytes and CD8+ T Cell Subsets as Prognostic Markers in Patients with Surgically Treated Laryngeal Squamous Cell Carcinoma.. Head Neck Pathol. 14(3), 689-700.
Tragiannidis, A., Papageorgiou M., Stamou M., Hatzipantelis E., Papageorgiou T., Giannopoulos A., et al. (2016).  Tumor lysis-like syndrome in a child during treatment for visceral leishmaniasis.. Int J Immunopathol Pharmacol. 29(3), 458-60.
Nikolaidi, A., Kotoula V., Koliou G-A., Giannoulatou E., Papadopoulou K., Zagouri F., et al. (2020).  Tumor Mutational Patterns and Infiltrating Lymphocyte Density in Young and Elderly Patients With Breast Cancer.. Cancer Genomics Proteomics. 17(2), 181-193.
Aslanidis, S., Pyrpasopoulou A., Triantafyllou A., Anyfanti P., Zamboulis C., & Douma S. (2010).  Tumor necrosis factor antagonist-associated neutropenia: comment on the article by Hastings et al.. Arthritis Care Res (Hoboken). 62(12), 1813-5; author reply 1815.
Aslanidis, S., Pyrpasopoulou A., Douma S., & Triantafyllou A. (2008).  Tumor necrosis factor-a antagonist-induced psoriasis: yet another paradox in medicine.. Clin Rheumatol. 27(3), 377-80.
Vachliotis, I. D., Valsamidis I., & Polyzos S. A. (2023).  Tumor Necrosis Factor-Alpha and Adiponectin in Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma.. Cancers (Basel). 15(21), 
Zardavas, D., Marvelde L. Te, Milne R. L., Fumagalli D., Fountzilas G., Kotoula V., et al. (2018).  Tumor PIK3CA Genotype and Prognosis in Early-Stage Breast Cancer: A Pooled Analysis of Individual Patient Data.. J Clin Oncol. 36(10), 981-990.
Kolovou, V., Tsipis A., Mihas C., Katsiki N., Vartela V., Koutelou M., et al. (2018).  Tumor Protein p53 (TP53) Gene and Left Main Coronary Artery Disease.. Angiology. 69(8), 730-735.
Fegers, I., Kob R., Eckey M., Schmidt O., Goeman F., Papaioannou M., et al. (2007).  The tumor suppressors p33ING1 and p33ING2 interact with alien in vivo and enhance alien-mediated gene silencing.. J Proteome Res. 6(11), 4182-8.
Yavropoulou, M. P., Gerothanasi N., Frydas A., Triantafyllou E., Poulios C., Hytiroglou P., et al. (2015).  Tumor-induced osteomalacia due to a recurrent mesenchymal tumor overexpressing several growth factor receptors.. Endocrinol Diabetes Metab Case Rep. 2015, 150025.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.